|
[Related PubMed/MEDLINE]
Total Number of Papers: 394
|
|
|
|
|
[Display Entries]
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: NLCs |
| Long Form |
: nanostructured lipid carriers |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2020 |
A Gastric Cancer Peptide GX1-Modified Nano-Lipid Carriers Encapsulating Paclitaxel: Design and Evaluation of Anti-Tumor Activity. |
GX1-PTX-NLCs, PTX |
| 2 |
2020 |
A promising approach to develop nanostructured lipid carriers from solid lipid nanoparticles: preparation, characterization, cytotoxicity and nucleic acid binding ability. |
cNLCs, cSLNs, SLNs |
| 3 |
2020 |
A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer. |
BC, EGFR, ER, HER2, PR, SLNs, TNBC, VEGF |
| 4 |
2020 |
Analytical method development and validation of reverse-phase high-performance liquid chromatography (RP-HPLC) method for simultaneous quantifications of quercetin and piperine in dual-drug loaded nanostructured lipid carriers. |
PDA, RP-HPLC |
| 5 |
2020 |
Anti-microbial activity of curcumin nanoformulations: New trends and future perspectives. |
--- |
| 6 |
2020 |
Berberine-Loaded Nanostructured Lipid Carriers Enhance the Treatment of Ulcerative Colitis. |
BBR, BBR-NLCs, UC |
| 7 |
2020 |
beta-Sitosterol Loaded Nanostructured Lipid Carrier: Physical and Oxidative Stability, In Vitro Simulated Digestion and Hypocholesterolemic Activity. |
--- |
| 8 |
2020 |
Biotin anchored nanostructured lipid carriers for targeted delivery of doxorubicin in management of mammary gland carcinoma through regulation of apoptotic modulator. |
DOX |
| 9 |
2020 |
Carvacrol loaded nanostructured lipid carriers as a promising parenteral formulation for leishmaniasis treatment. |
CL, MRT |
| 10 |
2020 |
Chitosan coated nanostructured lipid carriers for enhanced in vivo efficacy of albendazole against Trichinella spiralis. |
--- |
| 11 |
2020 |
Co-delivery of rituximab targeted curcumin and imatinib nanostructured lipid carriers in non-Hodgkin lymphoma cells. |
--- |
| 12 |
2020 |
Coated Lipidic Nanoparticles as a New Strategy for Enhancing Nose-to-Brain Delivery of a Hydrophilic Drug Molecule. |
ALM, CNS, EE, ZP |
| 13 |
2020 |
Design of nalidixic acid‑vanadium complex loaded into chitosan hybrid nanoparticles as smart strategy to inhibit bacterial growth and quorum sensing. |
CHI, NA |
| 14 |
2020 |
Design of ocular drug delivery platforms and in vitro - in vivo evaluation of riboflavin to the cornea by non-interventional (epi-on) technique for keratoconus treatment. |
--- |
| 15 |
2020 |
Development of folic acid-loaded nanostructured lipid carriers for topical delivery: preparation, characterisation and ex vivo investigation. |
FA, UV |
| 16 |
2020 |
Development of Nanostructured Lipid Carriers for the Delivery of Idebenone in Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay. |
BBB, IDE, ROS, SACS |
| 17 |
2020 |
Dexmedetomidine and levobupivacaine co-loaded, transcriptional transactivator peptide modified nanostructured lipid carriers or lipid-polymer hybrid nanoparticles, which performed better for local anesthetic therapy? |
DEX, LAs, LEV, LPNs, Tat |
| 18 |
2020 |
Effect of nanostructured lipid carriers on transdermal delivery of tenoxicam in irradiated rats. |
EE, NSAIDs, PDI, TNX |
| 19 |
2020 |
Ellagic Acid Containing Nanostructured Lipid Carriers for Topical Application: A Preliminary Study. |
EA, FRAP, SAXS |
| 20 |
2020 |
Encapsulation of Oleuropein in Nanostructured Lipid Carriers: Biocompatibility and Antioxidant Efficacy in Lung Epithelial Cells. |
OLE |
| 21 |
2020 |
Enhanced Pharmacokinetic Activity of Zotepine via Nanostructured Lipid Carrier System in Wistar Rats for Oral Application. |
DSC, PK, SEM, XRD, ZT, ZT-CS |
| 22 |
2020 |
Enhanced Transdermal Delivery of Concentrated Capsaicin from Chili Extract-Loaded Lipid Nanoparticles with Reduced Skin Irritation. |
EE, HET-CAM, LC, SLNs |
| 23 |
2020 |
Evaluation of lipid nanoparticles for topical delivery of protocatechuic acid and ethyl protocatechuate as a new photoprotection strategy. |
SLNs |
| 24 |
2020 |
Formulation of Stattic as STAT3 inhibitor in nanostructured lipid carriers (NLCs) enhances efficacy of doxorubicin in melanoma cancer cells. |
SEM |
| 25 |
2020 |
Formulation, optimization, and in vitro evaluation of nanostructured lipid carriers for topical delivery of Apremilast. |
APM, PDI, ZP |
| 26 |
2020 |
Improved Transmucosal Delivery of Glimepiride via Unidirectional Release Buccal Film Loaded With Vitamin E TPGS-Based Nanocarrier. |
GMD |
| 27 |
2020 |
Lipid Nanoparticles as a Skin Wound Healing Drug Delivery System: Discoveries and Advances. |
LNPs, SLNs |
| 28 |
2020 |
Lipid Nanoparticles for Enhancing the Physicochemical Stability and Topical Skin Delivery of Orobol. |
SLNs |
| 29 |
2020 |
Lipid-based nanocarrier-mediated targeted delivery of celecoxib attenuate severity of ulcerative colitis. |
COX-2 |
| 30 |
2020 |
Lipid-nanopotentiated combinatorial delivery of tamoxifen and sulforaphane: ex vivo, in vivo and toxicity studies. |
SFN, TAM |
| 31 |
2020 |
Luliconazole-loaded Nanostructured Lipid Carriers for Topical Treatment of Superficial Tinea infections. |
--- |
| 32 |
2020 |
Multiple Response Optimization of Beeswax-Based Nanostructured Lipid Carriers for the Controlled Release of Vitamin E. |
MCTs, NLC-VE |
| 33 |
2020 |
Mussel-Inspired Polydopamine Coating Enhances the Intracutaneous Drug Delivery from Nanostructured Lipid Carriers Dependently on a Follicular Pathway. |
HaCaT, PDA, TBF |
| 34 |
2020 |
Nanolipoidal alpha-terpineol modulates quorum sensing regulated virulence and biofilm formation in Pseudomonas aeruginosa. |
alphaT |
| 35 |
2020 |
Nanoparticle-mediated macrophage targeting-a new inhalation therapy tackling tuberculosis. |
LNZ, TP |
| 36 |
2020 |
Nanostructured Lipid Carriers (NLCs) for drug delivery: Role of Liquid lipid (oil). |
--- |
| 37 |
2020 |
Nanostructured Lipid Carriers (Nlcs): Nose-to-Brain Delivery and Theranostic Application. |
--- |
| 38 |
2020 |
Nanostructured Lipid Carriers as Potential Drug Delivery Systems for Skin Disorders. |
--- |
| 39 |
2020 |
Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review. |
SLNs |
| 40 |
2020 |
Nanostructured Lipid Carriers Made of Omega-3 Polyunsaturated Fatty Acids: In Vitro Evaluation of Emerging Nanocarriers to Treat Neurodegenerative Diseases. |
CNS, CS, DDS, LPS, ND, PDI |
| 41 |
2020 |
Nanostructured Lipid Carriers to Mediate Brain Delivery of Temazepam: Design and In Vivo Study. |
--- |
| 42 |
2020 |
Nanostructured lipid carriers with exceptional gastrointestinal stability and inhibition of P-gp efflux for improved oral delivery of tilmicosin. |
GI, TMS |
| 43 |
2020 |
Nanostructured lipid carriers- A versatile carrier for oral delivery of lipophilic drugs. |
--- |
| 44 |
2020 |
Nanostructured Lipid Carriers: A Groundbreaking Approach for Transdermal Drug Delivery. |
--- |
| 45 |
2020 |
Nanostructured lipid carriers: A novel hair protective product preventing hair damage and discoloration from UV radiation and thermal treatment. |
Vit E-NLCs |
| 46 |
2020 |
Optimization of Rifapentine-Loaded Lipid Nanoparticles Using a Quality-by-Design Strategy. |
EE, LC, RPT, TB |
| 47 |
2020 |
Optimized Nanostructured Lipid Carriers Integrated into In Situ Nasal Gel for Enhancing Brain Delivery of Flibanserin. |
FLB |
| 48 |
2020 |
Oral Bioavailability Enhancement of Raloxifene with Nanostructured Lipid Carriers. |
DSC, EE, RLX |
| 49 |
2020 |
Oral delivery of oleuropein-loaded lipid nanocarriers alleviates inflammation and oxidative stress in acute colitis. |
IBD, OLE, ROS |
| 50 |
2020 |
Physically Optimized Nano-Lipid Carriers Augment Raloxifene and Vitamin D Oral Bioavailability in Healthy Humans for Management of Osteoporosis. |
RLX, Vit.D |
| 51 |
2020 |
Preparation of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Drug Delivery and the Effects of Preparation Parameters of Solvent Injection Method. |
SLNs |
| 52 |
2020 |
Pulmonary delivery of nanostructured lipid carriers for effective repurposing of salinomycin as an antiviral agent. |
SAL |
| 53 |
2020 |
Pumpkin Oil-Based Nanostructured Lipid Carrier System for Antiulcer Effect in NSAID-Induced Gastric Ulcer Model in Rats. |
LL, NSAID, PSO |
| 54 |
2020 |
QbD-driven development of intranasal lipid nanoparticles for depression treatment. |
CQAs |
| 55 |
2020 |
Resveratrol: Isolation, and Its Nanostructured, Inhibits Cell Proliferation, Induces Cell Apoptosis in Certain Human Cell Lines Carcinoma and Exerts Protective Effect Against Paraquat-Induced Hepatotoxicity. |
CSNLCs, LDH, MCF-7, RES |
| 56 |
2020 |
S-Protected thiolated nanostructured lipid carriers exhibiting improved mucoadhesive properties. |
EE, LC, PDI |
| 57 |
2020 |
Sequential delivery of dual drugs with nanostructured lipid carriers for improving synergistic tumor treatment effect. |
CUR, TMZ |
| 58 |
2020 |
Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as Smart Drug Delivery Systems in the Treatment of Glioblastoma Multiforme. |
BBB, CNS, GBM, SLNs |
| 59 |
2020 |
Strategies to enhance oral delivery of amphotericin B: a comparison of uncoated and enteric-coated nanostructured lipid carriers. |
AmB |
| 60 |
2020 |
Sucupira Oil-Loaded Nanostructured Lipid Carriers (NLC): Lipid Screening, Factorial Design, Release Profile, and Cytotoxicity. |
DDS, DLS, DM, ELS, HPH, NLC, PI, ZP |
| 61 |
2020 |
Synergic pro-apoptotic effects of Ferulic Acid and nanostructured lipid carrier in glioblastoma cells assessed through molecular and Delayed Luminescence studies. |
DL, FA |
| 62 |
2020 |
Synthesis of Tilmicosin Nanostructured Lipid Carriers for Improved Oral Delivery in Broilers: Physiochemical Characterization and Cellular Permeation. |
P-pg, TMS |
| 63 |
2020 |
The influence of oil composition on the transformation, bioaccessibility, and intestinal absorption of curcumin in nanostructured lipid carriers. |
CUR, GTS, MCT |
| 64 |
2020 |
[Effect of nanostructured lipid carriers (NLCs) in improving stability of essential oils and its application]. |
--- |
| 65 |
2019 |
A comparative study: the prospective influence of nanovectors in leveraging the chemopreventive potential of COX-2 inhibitors against skin cancer. |
COX-2, ETD, N-Phsoms, P-Phsoms, PCNA-mRNA, SCC |
| 66 |
2019 |
Accelerated infected wound healing by topical application of encapsulated Rosemary essential oil into nanostructured lipid carriers. |
REO |
| 67 |
2019 |
Amphotericin B loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carrier (NLCs): physicochemical and solid-solution state characterizations. |
AmB, DSC, FT-IR, HSM, PXRD, SLNs |
| 68 |
2019 |
Asenapine maleate-loaded nanostructured lipid carriers: optimization and in vitro, ex vivo and in vivo evaluations. |
ASPM |
| 69 |
2019 |
Brain Delivery of Curcumin Using Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Preparation, Optimization, and Pharmacokinetic Evaluation. |
CNS, SLNs |
| 70 |
2019 |
Coated nanostructured lipid carriers targeting the joints - An effective and safe approach for the oral management of rheumatoid arthritis. |
ChS, CS, LEF, RA |
| 71 |
2019 |
Colloidal nanostructured lipid carriers of pentoxifylline produced by microwave irradiation ameliorates imiquimod-induced psoriasis in mice. |
PTX |
| 72 |
2019 |
Compatibility analysis of bergapten with different pharmaceutical excipients used in nanostructured lipid carriers. |
FTIR, NPs |
| 73 |
2019 |
Curcumin-loaded nanostructured lipid carriers prepared using Peceol™ and olive oil in photodynamic therapy: development and application in breast cancer cell line. |
CUR, PS, RSM, ZP |
| 74 |
2019 |
Cyproterone acetate-loaded nanostructured lipid carriers: effect of particle size on skin penetration and follicular targeting. |
CPA |
| 75 |
2019 |
Data on optimization and drug release kinetics of nanostructured lipid carriers containing ondansetron hydrochloride prepared by cold high-pressure homogenization method. |
DL, EE, OSH, PI, PS |
| 76 |
2019 |
Design and Optimization of Nanostructured Lipid Carrier Containing Dexamethasone for Ophthalmic Use. |
DXM |
| 77 |
2019 |
Development and characterization of nanostructured lipid carrier-based gels for the transdermal delivery of donepezil. |
DPB, NLC gel |
| 78 |
2019 |
Development of MART for the Rapid Production of Nanostructured Lipid Carriers Loaded with All-Trans Retinoic Acid for Dermal Delivery. |
ANN, ATRA, GA, MART, RSM |
| 79 |
2019 |
Development of nose-to-brain delivery of ketoconazole by nanostructured lipid carriers against cryptococcal meningoencephalitis in mice. |
BBB, KETO |
| 80 |
2019 |
Development, characterization and pharmacokinetics of mupirocin-loaded nanostructured lipid carriers (NLCs) for intravascular administration. |
M-NLC, PDI, ZP |
| 81 |
2019 |
Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model. |
IMQ, PASI, PDI |
| 82 |
2019 |
Effect of lipid chain length on nanostructured lipid carriers: Comprehensive structural evaluation by scattering techniques. |
DLS, SANS, SLS, solid phases |
| 83 |
2019 |
Effect of Oil Content on Physiochemical Characteristics of gamma-Oryzanol-Loaded Nanostructured Lipid Carriers. |
DFM, DSC, FTIR, GO, TEM, XRD |
| 84 |
2019 |
Enhanced Oral Absorption of Amisulpride Via a Nanostructured Lipid Carrier-Based Capsules: Development, Optimization Applying the Desirability Function Approach and In Vivo Pharmacokinetic Study. |
AMS |
| 85 |
2019 |
Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema. |
CPP, CPPs, LN |
| 86 |
2019 |
Enzyme-Loaded Gel Core Nanostructured Lipid Carriers to Improve Treatment of Lysosomal Storage Diseases: Formulation and In Vitro Cellular Studies of Elosulfase Alfa-Loaded Systems. |
ERT |
| 87 |
2019 |
Excipient-excipient interactions in the development of nanocarriers: an innovative statistical approach for formulation decisions. |
--- |
| 88 |
2019 |
Experimental validation of biocompatible nanostructured lipid carriers of sophorolipid: Optimization, characterization and in-vitro evaluation. |
AFM, SANS, SEM, TEM |
| 89 |
2019 |
Fabrication and characterization of nanostructured lipid carriers (NLC) using a plant-based emulsifier: Quillaja saponin. |
DSC, HSO, NLC, O/W, SLNs, TEM |
| 90 |
2019 |
Formulation And Evaluation Of Nanostructured Lipid Carriers (NLCs) Of 20(S)-Protopanaxadiol (PPD) By Box-Behnken Design. |
EE, NLC, PDI, PPD |
| 91 |
2019 |
Formulation design, characterization, and in vitro and in vivo evaluation of nanostructured lipid carriers containing a bile salt for oral delivery of gypenosides. |
GPs |
| 92 |
2019 |
Freeze-Dried Lopinavir-Loaded Nanostructured Lipid Carriers for Enhanced Cellular Uptake and Bioavailability: Statistical Optimization, in Vitro and in Vivo Evaluations. |
LPV, PDI, PS, ZP |
| 93 |
2019 |
Impact of Nanostructured Lipid Carriers as an Artificial Tear Film in a Rabbit Evaporative Dry Eye Model. |
--- |
| 94 |
2019 |
Impact of nanostructured lipid carriers on dapsone delivery to the skin: in vitro and in vivo studies. |
--- |
| 95 |
2019 |
Improved Dermal Delivery of Cyclosporine A Loaded in Solid Lipid Nanoparticles. |
CsA, SLNs |
| 96 |
2019 |
In vivo Antiplasmodial Activity of Curcumin-Loaded Nanostructured Lipid Carriers. |
CUR, Cur-NLC, DDSs, PI, TEM |
| 97 |
2019 |
Lipid-based nano delivery of antimicrobials to control food-borne bacteria. |
SLNs |
| 98 |
2019 |
Long-term anesthetic analgesic effects: Comparison of tetracaine loaded polymeric nanoparticles, solid lipid nanoparticles, and nanostructured lipid carriers in vitro and in vivo. |
LAs, PLA NPs, SLNs, TTC |
| 99 |
2019 |
Metronidazole-loaded nanostructured lipid carriers to improve skin deposition and retention in the treatment of rosacea. |
MTZ |
| 100 |
2019 |
Multifunctional green supramolecular solvents for cost-effective production of highly stable astaxanthin-rich formulations from Haematococcus pluvialis. |
SUPRAS |
|
A Search Service for Abbreviation / Long Form
